Health ❯ Therapeutics ❯ Immunotherapy

Targeted Therapy

B Cell Inhibition NRF2 Inhibitors

Lung Tumors Reprogram Bone Marrow Progenitors as NRF2 Emerges as a Target

Preclinical inhibition of a stress-response pathway curtailed macrophage-driven suppression, boosting checkpoint therapy in mice.

Scientists Identify Key Mechanism Driving Epstein-Barr Virus Spread and Potential Therapeutic Target